Incyte (INCY) Selling, General & Administrative (2010 - 2026)
Incyte (INCY) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-1.52 Mn |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
2.17 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
-7.36 Mn |
| 10 |
Incyte |
19.62 Bn |
15.60 Bn |
1.17 Bn |
328.09 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
328.09 Mn |
| Dec 31, 2025 |
390.41 Mn |
| Sep 30, 2025 |
329.08 Mn |
| Jun 30, 2025 |
331.02 Mn |
| Mar 31, 2025 |
325.69 Mn |
| Dec 31, 2024 |
326.71 Mn |
| Sep 30, 2024 |
309.21 Mn |
| Jun 30, 2024 |
305.98 Mn |
| Mar 31, 2024 |
300.26 Mn |
| Dec 31, 2023 |
288.23 Mn |
| Sep 30, 2023 |
267.89 Mn |
| Jun 30, 2023 |
283.93 Mn |
| Mar 31, 2023 |
315.61 Mn |
| Dec 31, 2022 |
272.82 Mn |
| Sep 30, 2022 |
266.46 Mn |
| Jun 30, 2022 |
253.28 Mn |
| Mar 31, 2022 |
209.58 Mn |
| Dec 31, 2021 |
226.20 Mn |
| Sep 30, 2021 |
190.70 Mn |
| Jun 30, 2021 |
168.86 Mn |
